Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology

Thomas E. Yankeelov, William Rooney, Wei Huang, Jonathan P. Dyke, Xin Li, Luminita (Alina) Tudorica, Jing Huei Lee, Jason A. Koutcher, Charles Jr Springer

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The standard pharmacokinetic model for the analysis of MRI contrast reagent (CR) bolus-tracking (B-T) data assumes that the mean intracellular water molecule lifetime (τi) is effectively zero. This assertion is inconsistent with a considerable body of physiological measurements. Furthermore, theory and simulation show the B-T time-course shape to be very sensitive to the τi magnitude in the physiological range (hundreds of milliseconds to several seconds). Consequently, this standard model aspect can cause significant underestimations (factors of 2 or 3) of the two parameters usually determined: Ktrans, the vascular wall CR transfer rate constant, and ve, the CR distribution volume (the extracellular, extravascular space fraction). Analyses of animal model data confirmed two predicted behaviors indicative of this standard model inadequacy: (1) a specific temporal pattern for the mismatch between the best-fitted curve and data; and (2) an inverse dependence of the curve's Ktrans and ve magnitudes on the CR dose. These parameters should be CR, dose-independent. The most parsimonious analysis allowing for realistic τi values is the 'shutter-speed' model. Its application to the experimental animal data essentially eliminated the two standard model signature inadequacies. This paper reports the first survey for the extent of this 'shutter-speed effect' in human data. Retrospective analyses are made of clinical data chosen from a range of pathology (the active multiple sclerosis lesion, the invasive ductal carcinoma breast tumor, and osteosarcoma in the leg) that provides a wide variation, particularly of Ktrans. The signature temporal mismatch of the standard model is observed in all cases, and is essentially eliminated by use of the shutter-speed model. Pixel-by-pixel maps show that parameter values from the shutter-speed analysis are increased by more than a factor of 3 for some lesion regions. This endows the lesions with very high contrast, and reveals heterogeneities that are often not seen in the standard model maps. Normal muscle regions in the leg allow validation of the shutter-speed model Ktrans, ve, and τ i magnitudes, by comparison with results of previous careful rat leg studies not possible for human subjects.

Original languageEnglish (US)
Pages (from-to)173-185
Number of pages13
JournalNMR in Biomedicine
Volume18
Issue number3
DOIs
StatePublished - May 2005

Fingerprint

Pathology
Leg
Ductal Carcinoma
Extracellular Space
Osteosarcoma
Animals
Multiple Sclerosis
Pixels
Blood Vessels
Animal Models
Pharmacokinetics
Breast Neoplasms
Muscles
Water
Magnetic resonance imaging
Muscle
Rats
Tumors
Rate constants
Molecules

Keywords

  • Bolus-tracking
  • Contrast reagent
  • Invasive ductal carcinoma
  • Multiple sclerosis
  • Osteosarcoma

ASJC Scopus subject areas

  • Spectroscopy
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Biophysics

Cite this

Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology. / Yankeelov, Thomas E.; Rooney, William; Huang, Wei; Dyke, Jonathan P.; Li, Xin; Tudorica, Luminita (Alina); Lee, Jing Huei; Koutcher, Jason A.; Springer, Charles Jr.

In: NMR in Biomedicine, Vol. 18, No. 3, 05.2005, p. 173-185.

Research output: Contribution to journalArticle

@article{dc12813a12084379a83b419d6fd2a245,
title = "Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology",
abstract = "The standard pharmacokinetic model for the analysis of MRI contrast reagent (CR) bolus-tracking (B-T) data assumes that the mean intracellular water molecule lifetime (τi) is effectively zero. This assertion is inconsistent with a considerable body of physiological measurements. Furthermore, theory and simulation show the B-T time-course shape to be very sensitive to the τi magnitude in the physiological range (hundreds of milliseconds to several seconds). Consequently, this standard model aspect can cause significant underestimations (factors of 2 or 3) of the two parameters usually determined: Ktrans, the vascular wall CR transfer rate constant, and ve, the CR distribution volume (the extracellular, extravascular space fraction). Analyses of animal model data confirmed two predicted behaviors indicative of this standard model inadequacy: (1) a specific temporal pattern for the mismatch between the best-fitted curve and data; and (2) an inverse dependence of the curve's Ktrans and ve magnitudes on the CR dose. These parameters should be CR, dose-independent. The most parsimonious analysis allowing for realistic τi values is the 'shutter-speed' model. Its application to the experimental animal data essentially eliminated the two standard model signature inadequacies. This paper reports the first survey for the extent of this 'shutter-speed effect' in human data. Retrospective analyses are made of clinical data chosen from a range of pathology (the active multiple sclerosis lesion, the invasive ductal carcinoma breast tumor, and osteosarcoma in the leg) that provides a wide variation, particularly of Ktrans. The signature temporal mismatch of the standard model is observed in all cases, and is essentially eliminated by use of the shutter-speed model. Pixel-by-pixel maps show that parameter values from the shutter-speed analysis are increased by more than a factor of 3 for some lesion regions. This endows the lesions with very high contrast, and reveals heterogeneities that are often not seen in the standard model maps. Normal muscle regions in the leg allow validation of the shutter-speed model Ktrans, ve, and τ i magnitudes, by comparison with results of previous careful rat leg studies not possible for human subjects.",
keywords = "Bolus-tracking, Contrast reagent, Invasive ductal carcinoma, Multiple sclerosis, Osteosarcoma",
author = "Yankeelov, {Thomas E.} and William Rooney and Wei Huang and Dyke, {Jonathan P.} and Xin Li and Tudorica, {Luminita (Alina)} and Lee, {Jing Huei} and Koutcher, {Jason A.} and Springer, {Charles Jr}",
year = "2005",
month = "5",
doi = "10.1002/nbm.938",
language = "English (US)",
volume = "18",
pages = "173--185",
journal = "NMR in Biomedicine",
issn = "0952-3480",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology

AU - Yankeelov, Thomas E.

AU - Rooney, William

AU - Huang, Wei

AU - Dyke, Jonathan P.

AU - Li, Xin

AU - Tudorica, Luminita (Alina)

AU - Lee, Jing Huei

AU - Koutcher, Jason A.

AU - Springer, Charles Jr

PY - 2005/5

Y1 - 2005/5

N2 - The standard pharmacokinetic model for the analysis of MRI contrast reagent (CR) bolus-tracking (B-T) data assumes that the mean intracellular water molecule lifetime (τi) is effectively zero. This assertion is inconsistent with a considerable body of physiological measurements. Furthermore, theory and simulation show the B-T time-course shape to be very sensitive to the τi magnitude in the physiological range (hundreds of milliseconds to several seconds). Consequently, this standard model aspect can cause significant underestimations (factors of 2 or 3) of the two parameters usually determined: Ktrans, the vascular wall CR transfer rate constant, and ve, the CR distribution volume (the extracellular, extravascular space fraction). Analyses of animal model data confirmed two predicted behaviors indicative of this standard model inadequacy: (1) a specific temporal pattern for the mismatch between the best-fitted curve and data; and (2) an inverse dependence of the curve's Ktrans and ve magnitudes on the CR dose. These parameters should be CR, dose-independent. The most parsimonious analysis allowing for realistic τi values is the 'shutter-speed' model. Its application to the experimental animal data essentially eliminated the two standard model signature inadequacies. This paper reports the first survey for the extent of this 'shutter-speed effect' in human data. Retrospective analyses are made of clinical data chosen from a range of pathology (the active multiple sclerosis lesion, the invasive ductal carcinoma breast tumor, and osteosarcoma in the leg) that provides a wide variation, particularly of Ktrans. The signature temporal mismatch of the standard model is observed in all cases, and is essentially eliminated by use of the shutter-speed model. Pixel-by-pixel maps show that parameter values from the shutter-speed analysis are increased by more than a factor of 3 for some lesion regions. This endows the lesions with very high contrast, and reveals heterogeneities that are often not seen in the standard model maps. Normal muscle regions in the leg allow validation of the shutter-speed model Ktrans, ve, and τ i magnitudes, by comparison with results of previous careful rat leg studies not possible for human subjects.

AB - The standard pharmacokinetic model for the analysis of MRI contrast reagent (CR) bolus-tracking (B-T) data assumes that the mean intracellular water molecule lifetime (τi) is effectively zero. This assertion is inconsistent with a considerable body of physiological measurements. Furthermore, theory and simulation show the B-T time-course shape to be very sensitive to the τi magnitude in the physiological range (hundreds of milliseconds to several seconds). Consequently, this standard model aspect can cause significant underestimations (factors of 2 or 3) of the two parameters usually determined: Ktrans, the vascular wall CR transfer rate constant, and ve, the CR distribution volume (the extracellular, extravascular space fraction). Analyses of animal model data confirmed two predicted behaviors indicative of this standard model inadequacy: (1) a specific temporal pattern for the mismatch between the best-fitted curve and data; and (2) an inverse dependence of the curve's Ktrans and ve magnitudes on the CR dose. These parameters should be CR, dose-independent. The most parsimonious analysis allowing for realistic τi values is the 'shutter-speed' model. Its application to the experimental animal data essentially eliminated the two standard model signature inadequacies. This paper reports the first survey for the extent of this 'shutter-speed effect' in human data. Retrospective analyses are made of clinical data chosen from a range of pathology (the active multiple sclerosis lesion, the invasive ductal carcinoma breast tumor, and osteosarcoma in the leg) that provides a wide variation, particularly of Ktrans. The signature temporal mismatch of the standard model is observed in all cases, and is essentially eliminated by use of the shutter-speed model. Pixel-by-pixel maps show that parameter values from the shutter-speed analysis are increased by more than a factor of 3 for some lesion regions. This endows the lesions with very high contrast, and reveals heterogeneities that are often not seen in the standard model maps. Normal muscle regions in the leg allow validation of the shutter-speed model Ktrans, ve, and τ i magnitudes, by comparison with results of previous careful rat leg studies not possible for human subjects.

KW - Bolus-tracking

KW - Contrast reagent

KW - Invasive ductal carcinoma

KW - Multiple sclerosis

KW - Osteosarcoma

UR - http://www.scopus.com/inward/record.url?scp=14744305898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14744305898&partnerID=8YFLogxK

U2 - 10.1002/nbm.938

DO - 10.1002/nbm.938

M3 - Article

VL - 18

SP - 173

EP - 185

JO - NMR in Biomedicine

JF - NMR in Biomedicine

SN - 0952-3480

IS - 3

ER -